Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.895
-0.080 (-4.05%)
Jun 13, 2025, 4:00 PM - Market closed
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $180.03 million as of June 13, 2025. Its market cap has decreased by -19.79% in one year.
Market Cap
180.03M
Enterprise Value
122.50M
1-Year Change
-19.79%
Ranking
Category
Stock Price
$1.90
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $180.03M, an increase of 43.78%. That is a compound annual growth rate of 3.04%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 725.92B |
| Johnson & Johnson | 373.57B |
| Novo Nordisk | 353.21B |
| AbbVie | 338.27B |
| UnitedHealth Group | 281.72B |
| Abbott Laboratories | 235.37B |
| Novartis AG | 231.84B |
| AstraZeneca | 229.07B |